Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 1;35(1):45-54.
doi: 10.1097/WCO.0000000000001011.

Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion

Giulio Bicciato  1 , Markus Arnold, Aidan Gebhardt, Mira Katan
Affiliations
Review

Precision medicine in secondary prevention of ischemic stroke: how may blood-based biomarkers help in clinical routine? An expert opinion

Giulio Bicciato et al. Curr Opin Neurol. .

Abstract

Purpose of review: One in eight patients unfortunately suffers a new stroke within 5 years of their first stroke, even today. Research in precision medicine could lead to a more individualized treatment allocation, possibly achieving lower recurrence rates of ischemic stroke. In this narrative review, we aim to discuss potential clinical implementation of several promising candidate blood biomarkers.

Recent findings: We discuss specifically some promising blood-based biomarkers, which may improve the identification of underlying causes as well as risk stratification of patients according to their specific cerebrovascular risk factor pattern.

Summary: Multimodal profiling of ischemic stroke patients by means of blood biomarkers, in addition to established clinical and neuroradiological data, may allow in the future a refinement of decision algorithms for treatment allocation in secondary ischemic stroke prevention.

PubMed Disclaimer

References

    1. Esenwa C, Gutierrez J. Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag 2015; 11:437–450.
    1. Flach C, Muruet W, Wolfe CDA, et al. Risk and secondary prevention of stroke recurrence: a population-base cohort study. Stroke 2020; 51:2435–2444.
    1. Khanevski AN, Bjerkreim AT, Novotny V, et al. NOR-STROKE study group. Recurrent ischemic stroke: incidence, predictors, and impact on mortality. Acta Neurol Scand 2019; 140:3–8.
    1. Zheng S, Yao B. Impact of risk factors for recurrence after the first ischemic stroke in adults: a systematic review and meta-analysis. J Clin Neurosci 2019; 60:24–30.
    1. Boehme C, Toell T, Mayer L, et al. The dimension of preventable stroke in a large representative patient cohort. Neurology 2019; 93:e2121–e2132.